Respiratory syncytial virus prophylaxis in preterm infants: a cost-effectiveness study from Turkey.

@article{Oncel2012RespiratorySV,
  title={Respiratory syncytial virus prophylaxis in preterm infants: a cost-effectiveness study from Turkey.},
  author={Mehmet Yekta Oncel and Banu Mutlu and Sumru Kavurt and Ahmet Yagmur Bas and Nihal Demirel and Mesut Akyol and Omer Erdeve and Uğur Dilmen},
  journal={The Turkish journal of pediatrics},
  year={2012},
  volume={54 4},
  pages={344-51}
}
The main aim of this study was to evaluate the cost-effectiveness of respiratory syncytial virus (RSV) prophylaxis with palivizumab in Turkey, by comparing hospitalization rates and costs as well as results of risk analyses in preterm infants who were treated either with palivizumab or conservatively. This retrospective study was undertaken in two centers on infants born with a gestational age of ≤32 weeks during the 2010-2011 seasons. Patients were divided into two groups based on status of… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 4 times over the past 90 days. VIEW TWEETS
6 Citations
25 References
Similar Papers

References

Publications referenced by this paper.
Showing 1-10 of 25 references

Cost effectiveness of respiratory syncytial virus prophylaxis: a critical and systematic review

  • Prescott WA, F Doloresco, J Brown, JA Paladino
  • Pharmacoeconomics
  • 2010

RSV Proflaksisi için Türk Neonatoloji Derne ğ i Önerileri

  • I Roeckl-Wiedmann, JG Liese, E Grill, B Fischer, D Carr, BH Belohradsky
  • Türk Neonatoloji Derne ğ i Bülteni
  • 2007

için Türk Neonatoloji Derneği Önerileri

  • RSV Proflaksis
  • Türk Neonatoloji Derneği Bülteni
  • 2007

Similar Papers

Loading similar papers…